del Carmen Marcela G, Avila-Wallace Maria
Division of Gynecologic Oncology, Vincent Obstetrics and Gynecology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA.
Clin Obstet Gynecol. 2013 Mar;56(1):65-75. doi: 10.1097/GRF.0b013e31827af75a.
Significant declines in the incidence and mortality rates of cervical cancer have occurred in the United States since the introduction of the Papanicolaou (Pap) test. Unfortunately, a reduction in the burden of cervical cancer is not equal across all ethnic and racial groups; significant disparities exist. Disparities are reflected not only in mortality and incidence rates, but also in screening rates. We review barriers to screening and effective approaches towards overcoming them. As minority populations increase over the next few decades, it becomes ever more urgent to employ interventions that will reduce the burden of cervical cancer among diverse groups.
自帕潘icolaou（巴氏）试验引入以来，美国宫颈癌的发病率和死亡率显著下降。不幸的是，宫颈癌负担的减轻在所有族裔和种族群体中并不均衡；存在显著差异。这些差异不仅体现在死亡率和发病率上，也体现在筛查率上。我们回顾了筛查的障碍以及克服这些障碍的有效方法。随着少数族裔人口在未来几十年不断增加，采用能够减轻不同群体宫颈癌负担的干预措施变得更加紧迫。
